Here are several more breaking news stories which could affect market stocks in trading later today.
The following companies should see some movement: Sunoco (NYSE:SUN), Northrop Grumman (NYSE:NOC), Pfizer Inc. (NYSE:PFE).
Here is a more detailed look at the news that will affect each company when trading continues.
Sunoco (NYSE:SUN) has shut the crude oil pipeline in Oklahoma after finding a leak on Wednesday.
The company told government regulators that the 1,250-barrel spill in Garvin County, south of Oklahoma City, has caused no injuries.
This 10-inch line runs about 20 miles from Eola to Maysville and the cleanup is under progress.
The company Spokesman Thomas Golembeski said that “The cause of the release is being investigated and Sunoco (NYSE:SUN) do not think any refineries are directly supplied by this line.”
Northrop Grumman (NYSE:NOC)
Northrop Grumman (NYSE:NOC) has appointed Jennifer McGarey as its new corporate VP and secretary.
In her new role, McGarey will be responsible for corporate governance and securities compliance and will act as a channel of communication and information among Northrop Grumman’s (NYSE:NOC) leadership and board.
She will be reporting to Sheila Cheston, corporate vice president and general counsel of Northrop Grumman (NYSE:NOC).Cheston said, “McGarey’s experience as a corporate secretary, as well as her legal, financial and human resources expertise will be invaluable in her new role with our company. I look forward to her making immediate contributions that deliver value for our shareholders, customers and employees.”
Pfizer Inc. (NYSE:PFE)
Pfizer (NYSE:PFE) has agreed to pay $632 million to Theraclone for research programs.
Report says that the world’s largest drug maker, Pfizer (NYSE:PFE) will pay up to $632 million to Seattle-based Theraclone Sciences in a research collaboration on antibody drugs for cancer and infectious disease. Theraclone will use this upfront payment as a technology-access fee on two unspecified targets in oncology and two unspecified goals in infectious disease.
Jose-Carlos Gutierrez-Ramos, Pfizer’s (NYSE:PFE) senior vice president and head of biotherapeutics research said, “This fits in the big picture of us wanting to be on the leading edge of biotherapeutics and antibody discovery, and this is one company we are very excited to work with.”
Expect more movement when trading continues for Sunoco (NYSE:SUN), Northrop Grumman (NYSE:NOC) and Pfizer Inc. (NYSE:PFE).